ENTITY
Ligand Pharmaceuticals

Ligand Pharmaceuticals (LGND US)

13
Analysis
Health Care • United States
Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.
more
Exchange Announcement • 08 Nov 2025 05:04
Exchange Announcement • 06 Nov 2025 20:08
Exchange Announcement • 17 Sep 2025 05:19
Exchange Announcement • 15 Aug 2025 04:41
Exchange Announcement • 11 Aug 2025 19:25
x